Shu Lin
- Endocrine and Autonomic Systems top 0.2%
- Regulation of Appetite and Obesity 42
-
- Neuropeptides and Animal Physiology 35
- Physiology top 1%
- Adipose Tissue and Metabolism 14
- Molecular Biology top 2%
- Extracellular vesicles in disease 15
- Epigenetics and DNA Methylation 13
- Genomics and Chromatin Dynamics 11
- Nutrition and Dietetics top 1%
- Biochemical Analysis and Sensing Techniques 11
-
- MicroRNA in disease regulation 12
Shu Lin
176 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Endocrine and Autonomic Systems 1.8k
- Cellular and Molecular Neuroscience 1.3k
- Physiology 1.7k
- Molecular Biology 3.3k
- Nutrition and Dietetics 715
Countries citing papers authored by Shu Lin
This map shows the geographic impact of Shu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Lin more than expected).
Fields of papers citing papers by Shu Lin
This network shows the impact of papers produced by Shu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Lin. The network helps show where Shu Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 58 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 15 | |
| 16 | 2021 | 10 | |
| 17 | Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastomabreakdown → | 2013 | 898 |
| 18 | 2012 | 34 | |
| 19 | 2010 | 81 | |
| 20 | 2009 | 60 |
About Shu Lin
Shu Lin is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 180 papers that have together received 7.6k indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (42 papers), Neuropeptides and Animal Physiology (35 papers), Extracellular vesicles in disease (15 papers), Adipose Tissue and Metabolism (14 papers), Epigenetics and DNA Methylation (13 papers), MicroRNA in disease regulation (12 papers), Genomics and Chromatin Dynamics (11 papers) and Biochemical Analysis and Sensing Techniques (11 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.8k citations), Cellular and Molecular Neuroscience (1.3k citations) and Physiology (1.7k citations). Shu Lin has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Xu‐Feng Huang, Herbert Herzog, Benjamin A. García, Amanda Sainsbury, Yan‐Chuan Shi, Dana Boey, C. David Allis, Laura A. Banaszynski, Manuel M. Müller and Oren J. Becher. Their work appears in journals such as Science, Chemical Reviews and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.